Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

BRAF

  • You have access
    Cumulative Incidence of Thromboembolism and Prognostic Impact of Stroke in BRAF V600E-mutant Non-small-cell Lung Cancer
    SHO YAMADA, AKIMASA SEKINE, ERI HAGIWARA, YOKO ONODERA, ERINA TABATA, SATOSHI IKEDA, HIDEYA KITAMURA, TOMOHISA BABA, SHIGERU KOMATSU and TAKASHI OGURA
    Anticancer Research February 2023, 43 (2) 935-938; DOI: https://doi.org/10.21873/anticanres.16237
  • You have access
    Panniculitis Under Successful Targeted Inhibition of the MAPK/ERK Signaling Pathway in a Patient With BRAF V600E-mutated Spindle Cell Oncocytoma of the Pituitary Gland
    LUKAS SOLLFRANK, SEBASTIAN LETTMAIER, MICHAEL ERDMANN and UGUR USLU
    Anticancer Research July 2019, 39 (7) 3955-3959; DOI: https://doi.org/10.21873/anticanres.13549
  • You have access
    Separating Response of Tumor and non-Tumor Cells to Drug In Vitro by Quantifying a Mutation
    MARKUS KLEINPOPPEN, CHRISTOPH MOEBIUS, KATHARINA GRUPP, LAN KLUWE and MARCO BLESSMANN
    Anticancer Research April 2019, 39 (4) 1777-1783; DOI: https://doi.org/10.21873/anticanres.13284
  • You have access
    Molecular Subtypes Are Frequently Discordant Between Lesions in Patients With Synchronous Colorectal Cancer: Molecular Analysis of 59 Patients
    KEIICHI ARAKAWA, KEISUKE HATA, HIROAKI NOZAWA, KAZUSHIGE KAWAI, TOSHIAKI TANAKA, TAKESHI NISHIKAWA, KAZUHITO SASAKI, YASUTAKA SHUNO, MANABU KANEKO, MASAYA HIYOSHI, SHIGENOBU EMOTO, KOJI MURONO, HIROFUMI SONODA, SATOSHI OKADA and SOICHIRO ISHIHARA
    Anticancer Research March 2019, 39 (3) 1425-1432; DOI: https://doi.org/10.21873/anticanres.13258
  • You have access
    Pharmacological Inhibition of Casein Kinase 2 Enhances the Effectiveness of PI3K Inhibition in Colon Cancer Cells
    CRYSTAL SEMAAN, KARLIE A. NEILSON, BENJAMIN BROWN and MARK P. MOLLOY
    Anticancer Research November 2018, 38 (11) 6195-6200; DOI: https://doi.org/10.21873/anticanres.12973
  • You have access
    Double KRAS and BRAF Mutations in Surgically Treated Colorectal Cancer Liver Metastases: An International, Multi-institutional Case Series
    AMAR DESHWAR, GEORGIOS ANTONIOS MARGONIS, NIKOLAOS ANDREATOS, CARLOTTA BARBON, JAEYUN WANG, STEFAN BUETTNER, DORIS WAGNER, KAZUNARI SASAKI, ANDREA BEER, INGER MARIE LØES, EMMANOUIL PIKOULIS, CHRISTOS DAMASKOS, NIKOLAOS GARMPIS, KARSTEN KAMPHUES, JIN HE, KLAUS KACZIREK, GEORGE POULTSIDES, PER EYSTEIN LØNNING, HANS JOERG MISCHINGER, FEDERICO N. AUCEJO, MARTIN E. KREIS, CHRISTOPHER L. WOLFGANG and MATTHEW J. WEISS
    Anticancer Research May 2018, 38 (5) 2891-2895;
  • You have access
    BRAF Inhibitors and Radiation Do Not Act Synergistically to Inhibit WT and V600E BRAF Human Melanoma
    LISA WALTER and LUCIE HEINZERLING
    Anticancer Research March 2018, 38 (3) 1335-1341;
  • You have access
    MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers
    IDA V. LUNDBERG, MARIA L. WIKBERG, INGRID LJUSLINDER, XINGRU LI, ROBIN MYTE, CARL ZINGMARK, ANNA LÖFGREN-BURSTRÖM, SOFIA EDIN and RICHARD PALMQVIST
    Anticancer Research February 2018, 38 (2) 677-683;
  • You have access
    Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas
    DEMETRIOS MORIS, CHRISTOS DAMASKOS, ELEFTHERIOS SPARTALIS, ALEXANDROS PAPALAMPROS, SPYRIDON VERNADAKIS, DIMITRIOS DIMITROULIS, JOHN GRINIATSOS, EVANGELOS FELEKOURAS and NIKOLAOS NIKITEAS
    Anticancer Research May 2017, 37 (5) 2185-2194;
  • You have access
    Comparative Study of Mutations in Single Nucleotide Polymorphism Loci of KRAS and BRAF Genes in Patients Who Underwent Screening Colonoscopy, With and Without Premalignant Intestinal Polyps
    MICHAIL GALANOPOULOS, IOANNIS S. PAPANIKOLAOU, ELENI ZOGRAFOS, NIKOS VIAZIS, GEORGE PAPATHEODORIDIS, DIMITRIOS KARAMANOLIS, EVANGELOS MARINOS, GERASSIMOS J. MANTZARIS and MARIA GAZOULI
    Anticancer Research February 2017, 37 (2) 651-657;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire